TSX News -
Element Announces Renewal of Normal Course Issuer Bid
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Amounts in CAD unless otherwise noted […]
Puma Signs Non-Binding LOIs to Secure New High-Grade Gold Exploration Project in New Brunswick
RIMOUSKI, Québec, Nov. 18, 2024 (GLOBE NEWSWIRE) — Puma Exploration Inc. (TSXV: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) is […]
SONORO GOLD COMPLETES CONCESSION PAYMENT AND PROVIDES CORPORATE UPDATE
VANCOUVER, Canada, Nov. 18, 2024 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” […]
AgEagle Aerial Systems Invited to the White House for Key Discussions on Commercial Unmanned Aerial Vehicles (UAVs)
Key UAV stakeholders assembled with government officials to confer on U.S. drone technology matters WICHITA, Kan., Nov. 18, 2024 (GLOBE […]
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing […]
Genius Group launches Bitcoin Treasury with purchase of 110 Bitcoin for $10 million
SINGAPORE, Nov. 18, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading […]
Beyond Oil Secures C$1.77 Million in Funding Through Warrant Exercises, Led by Strategic Partner West Coast Reduction
VANCOUVER, B.C. and KIBBUTZ YIFAT, ISRAEL , Nov. 18, 2024 (GLOBE NEWSWIRE) — Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) […]
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Two patients exceed 14 months on treatment in Phase 2 trialof advanced ovarian cancer Allarity maintains a cash balance of […]
Sharps Regains Nasdaq Listing Compliance
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and […]
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
Patient population for the NAVIGATE trial is based on non-invasive tests and clinical criteria utilizing latest treatment guidelines for portal […]
